Ataluren Pharmacokinetics in Healthy Japanese and Caucasian Subjects
Author:
Affiliation:
1. PTC Therapeutics, Inc South Plainfield NJ USA
2. R2D Pharma Services LLC Princeton NJ USA
Funder
PTC Therapeutics
Publisher
Wiley
Subject
Pharmacology (medical),Pharmaceutical Science
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpdd.645
Reference34 articles.
1. Ataluren as an Agent for Therapeutic Nonsense Suppression
2. Ataluren treatment of patients with nonsense mutation dystrophinopathy
3. Advances in the Treatment of Duchenne Muscular Dystrophy: New and Emerging Pharmacotherapies
4. Phase 2a Study of Ataluren-Mediated Dystrophin Production in Patients with Nonsense Mutation Duchenne Muscular Dystrophy
5. Current and emerging treatment strategies for Duchenne muscular dystrophy
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Ataluren—Promising Therapeutic Premature Termination Codon Readthrough Frontrunner;Pharmaceuticals;2021-08-09
2. Ataluren for drug‐resistant epilepsy in nonsense variant‐mediated Dravet syndrome and CDKL5 deficiency disorder;Annals of Clinical and Translational Neurology;2021-02-04
3. Formulation and Stability of Ataluren Eye Drop Oily Solution for Aniridia;Pharmaceutics;2020-12-22
4. Deciphering the molecular mechanism of stop codon readthrough;Biological Reviews;2020-10-22
5. Safety issues and harmful pharmacological interactions of nutritional supplements in Duchenne muscular dystrophy: considerations for Standard of Care and emerging virus outbreaks;Pharmacological Research;2020-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3